HRP20230865T1 - Kompozicije egzosoma i postupci za njihovu pripremu i primjenu za reguliranje i kondicioniranje kože i kose - Google Patents
Kompozicije egzosoma i postupci za njihovu pripremu i primjenu za reguliranje i kondicioniranje kože i kose Download PDFInfo
- Publication number
- HRP20230865T1 HRP20230865T1 HRP20230865TT HRP20230865T HRP20230865T1 HR P20230865 T1 HRP20230865 T1 HR P20230865T1 HR P20230865T T HRP20230865T T HR P20230865TT HR P20230865 T HRP20230865 T HR P20230865T HR P20230865 T1 HRP20230865 T1 HR P20230865T1
- Authority
- HR
- Croatia
- Prior art keywords
- skin
- exosomes
- heat shock
- composition
- hair
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 15
- 210000001808 exosome Anatomy 0.000 title claims 14
- 238000000034 method Methods 0.000 title claims 9
- 230000001105 regulatory effect Effects 0.000 title claims 4
- 230000003750 conditioning effect Effects 0.000 title 1
- 230000035939 shock Effects 0.000 claims 13
- 239000002537 cosmetic Substances 0.000 claims 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 5
- 230000002500 effect on skin Effects 0.000 claims 3
- 230000003938 response to stress Effects 0.000 claims 3
- 239000004017 serum-free culture medium Substances 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 210000002950 fibroblast Anatomy 0.000 claims 2
- 235000011187 glycerol Nutrition 0.000 claims 2
- 229960005150 glycerol Drugs 0.000 claims 2
- 239000001963 growth medium Substances 0.000 claims 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims 2
- 230000003020 moisturizing effect Effects 0.000 claims 2
- 230000003169 placental effect Effects 0.000 claims 2
- 230000005855 radiation Effects 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- 102000007469 Actins Human genes 0.000 claims 1
- 108010085238 Actins Proteins 0.000 claims 1
- 241000195940 Bryophyta Species 0.000 claims 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims 1
- 101710163595 Chaperone protein DnaK Proteins 0.000 claims 1
- 208000032544 Cicatrix Diseases 0.000 claims 1
- 102000012422 Collagen Type I Human genes 0.000 claims 1
- 108010022452 Collagen Type I Proteins 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims 1
- 208000035874 Excoriation Diseases 0.000 claims 1
- 101710178376 Heat shock 70 kDa protein Proteins 0.000 claims 1
- 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 claims 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims 1
- 239000004264 Petrolatum Substances 0.000 claims 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 claims 1
- 229930003537 Vitamin B3 Natural products 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 235000006708 antioxidants Nutrition 0.000 claims 1
- 229940106189 ceramide Drugs 0.000 claims 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 229940008099 dimethicone Drugs 0.000 claims 1
- 239000004205 dimethyl polysiloxane Substances 0.000 claims 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 235000011929 mousse Nutrition 0.000 claims 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims 1
- 229960003512 nicotinic acid Drugs 0.000 claims 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 1
- 229940101267 panthenol Drugs 0.000 claims 1
- 150000002948 pantothenic acids Chemical class 0.000 claims 1
- 235000020957 pantothenol Nutrition 0.000 claims 1
- 239000011619 pantothenol Substances 0.000 claims 1
- 239000006072 paste Substances 0.000 claims 1
- 229940066842 petrolatum Drugs 0.000 claims 1
- 235000019271 petrolatum Nutrition 0.000 claims 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 231100000241 scar Toxicity 0.000 claims 1
- 230000037387 scars Effects 0.000 claims 1
- 230000036548 skin texture Effects 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 229930003799 tocopherol Natural products 0.000 claims 1
- 239000011732 tocopherol Substances 0.000 claims 1
- 150000003611 tocopherol derivatives Chemical class 0.000 claims 1
- 235000019149 tocopherols Nutrition 0.000 claims 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 claims 1
- 230000036572 transepidermal water loss Effects 0.000 claims 1
- 239000011708 vitamin B3 Substances 0.000 claims 1
- 235000019160 vitamin B3 Nutrition 0.000 claims 1
- -1 vitamin B3 compound Chemical class 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 claims 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/92—Medium free of human- or animal-derived components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2523/00—Culture process characterised by temperature
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems
Claims (15)
1. Topikalna kompozicija za reguliranje kozmetičkog stanja kože ili kose, kompozicija koja sadrži efikasnu količinu izoliranih egzosoma koji imaju povišene nivoe molekula odgovora na stres toplinskog šoka, pri čemu su izolirani egzosomi egzosomi toplinskog šoka izvedeni iz mezenhimalnih matičnih stanica podvrgnutih toplinskom šoku placentalnog ili adipoznog porijekla, i nosač i pri čemu su egzosomi toplinskog šoka proizvedeni postupkom koji obuhvaća:
(a) kultiviranje matičnih stanica u mediju za kulturu, pri čemu kultivacija uključuje korak toplinskog šokiranja matičnih stanica u mediju za kulturu bez seruma povećanjem temperaturu kulture na 41°C do 43 °C tokom 1 sata do 3 sata, i pri čemu medij za kulturu bez seruma sadrži egzosome koji imaju povišene nivoe molekula odgovora na stres toplinskog šoka; i
(b) izoliranje egzosoma koji imaju povišene nivoe molekula odgovora na stres toplinskog šoka iz medija bez seruma.
2. Kompozicija prema patentnom zahtjevu 1, pri čemu egzosomi toplinskog šoka imaju povišene nivoe HSP70 u odnosu na β-aktin u usporedbi sa usporedivim egzosomima izvedenim iz mezenhimalnih matičnih stanica placentalnog ili adipoznog porijekla kultiviranih bez toplinskog šoka.
3. Kompozicija iz bilo kojeg od patentnih zahtjeva 1-2, koja dalje sadrži od 0.1 do 20% sredstva za vlaženje, gdje po izboru sredstvo za vlaženje sadrži jedno ili više od pantenola, derivata pantotenske kiseline, glicerina, glicerola, dimetikona, vazelina, hijaluronske kiseline, ili ceremida, i njihovih smjesa.
4. Kompozicija iz bilo kojeg od patentnih zahtjeva 1-3, koja dalje sadrži spoj vitamina B3.
5. Kompozicija iz bilo kojeg od patentnih zahtjeva 1-3, koja dalje sadrži tokoferol nikotinat.
6. Kompozicija iz bilo kojeg od patentnih zahtjeva 1-3, koja dalje sadrži anti-oksidans, opcionalno jedan ili kombinaciju tokoferola ili estara tokoferola.
7. Kompozicija iz bilo kojeg od patentnih zahtjeva 1-6, pri čemu egzosomi toplinskog šoka su osušeni zamrzavanjem.
8. Kompozicija iz bilo kojeg od patentnih zahtjeva 1-7, pri čemu:
(a) medij za kulturu bez seruma je bez životinjskih proizvoda; i/ili
(b) kompozicija u obliku tekućine, losiona, kreme, gela, pjene, gušće pjene (mousse), spreja, paste, praha, ili čvrste supstance.
9. Kompozicija iz bilo kojeg od patentnih zahtjeva 1-8, pri čemu je kozmetičko stanje kože ili kose izazvano UVB zračenjem.
10. Postupak izrade topikalne kompozicije za reguliranje kozmetičkog stanja kože ili kose, pri čemu postupak obuhvaća kombiniranje efikasne količine egzosoma toplinskog šoka prema bilo kojem od patentnih zahtjeva 1-9 sa nosačem.
11. Postupak za reguliranje kozmetičkog stanja kože koji obuhvaća topikalno administriranje kompozicije prema bilo kojem od patentnih zahtjeva 1-9, pri čemu kozmetičko stanje kože obuhvaća integritet kože, sadržaj vode ili vlažnost kože, transepidermalni gubitak vode, perutanje kože, i ljuštenje, debljinu kože, zatezna svojstva kože, pojavu dermalnih finih linija i bora, teksturu kože, veličinu pora kože, glatkoću kože, staračke pjege na koži, ten kože, ili pojavu ožiljaka i abrazija kože.
12. Postupak prema patentnom zahtjevu 11, pri čemu egzosomi toplinskog šoka uključuju proizvodnju kolagena I dermalnih fibroblasta.
13. Postupak prema patentnom zahtjevu 11, pri čemu egzosomi toplinskog šoka induciraju proliferaciju dermalnih fibroblasta.
14. Postupak prema patentnom zahtjevu 11, pri čemu egzosomi toplinskog šoka inhibiraju eksprimiranje inflamatornih citokina.
15. Postupak iz bilo kojeg od patentnih zahtjeva 10-14, pri čemu kozmetičko stanje kože ili kose je uzrokovano UVB zračenjem.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562199696P | 2015-07-31 | 2015-07-31 | |
EP16833569.3A EP3328397B1 (en) | 2015-07-31 | 2016-07-28 | Exosome compositions and methods for preparation and use thereof for regulating and conditioning skin and hair |
PCT/US2016/044458 WO2017023690A1 (en) | 2015-07-31 | 2016-07-28 | Exosome compositions and methods for preparation and use thereof for regulating and conditioning skin and hair |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20230865T1 true HRP20230865T1 (hr) | 2023-11-10 |
Family
ID=57943605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20230865TT HRP20230865T1 (hr) | 2015-07-31 | 2016-07-28 | Kompozicije egzosoma i postupci za njihovu pripremu i primjenu za reguliranje i kondicioniranje kože i kose |
Country Status (10)
Country | Link |
---|---|
US (2) | US20180147420A1 (hr) |
EP (2) | EP3328397B1 (hr) |
JP (2) | JP6980955B2 (hr) |
CA (2) | CA2993227C (hr) |
ES (1) | ES2952050T3 (hr) |
HR (1) | HRP20230865T1 (hr) |
HU (1) | HUE063486T2 (hr) |
PL (1) | PL3328397T3 (hr) |
RS (1) | RS64469B1 (hr) |
WO (2) | WO2017023690A1 (hr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11596656B2 (en) * | 2016-08-23 | 2023-03-07 | Albert Einstein College Of Medicine | Stem cell-produced microvesicles for treating tendon pathologies |
CN107080753A (zh) * | 2017-04-20 | 2017-08-22 | 深圳市赛欧细胞生物科技有限公司 | 一种人脐带间充质干细胞源外泌体的美容制剂 |
CN107006452A (zh) * | 2017-04-20 | 2017-08-04 | 深圳市赛欧细胞生物科技有限公司 | 一种人脐带间充质干细胞源外泌体冻干保存方法及其应用 |
CN107245472B (zh) * | 2017-06-08 | 2021-08-06 | 北京智能宝生物科技有限公司 | 一种人间充质干细胞外泌体冻干粉的制备方法、使用方法 |
WO2019004738A2 (ko) * | 2017-06-30 | 2019-01-03 | 주식회사 엑소코바이오 | 지방줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부염 개선 용도 |
JP7037205B2 (ja) * | 2017-06-30 | 2022-03-16 | エクソコバイオ インコーポレイテッド | 幹細胞由来のエキソソームを有効成分として含む組成物のかゆみの抑制又は改善の用途 |
KR20190003316A (ko) | 2017-06-30 | 2019-01-09 | 주식회사 엑소코바이오 | 지방줄기세포 유래의 엑소좀 및/또는 세포외 소포체를 유효성분으로 포함하는 조성물의 피부염 개선 용도 |
WO2019040790A1 (en) * | 2017-08-23 | 2019-02-28 | Merakris Therapeutics, Llc | COMPOSITIONS CONTAINING AMNIOTIC COMPONENTS AND METHODS FOR THEIR PREPARATION AND USE |
CA3073762A1 (en) * | 2017-09-11 | 2019-03-14 | Symbiocelltech, Llc | Adaptation of hollow-fiber-based cell culture technology for the manufacturing of neo-islets or exosomes from stem cells |
CN111527199A (zh) * | 2017-11-16 | 2020-08-11 | 得克萨斯大学体系董事会 | 用于制备来源于msc的外泌体的方法 |
KR102039302B1 (ko) * | 2017-11-24 | 2019-10-31 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부장벽 강화 내지 기능 개선 용도 |
KR20190060646A (ko) * | 2017-11-24 | 2019-06-03 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀 및/또는 세포외 소포체를 유효성분으로 포함하는 조성물의 피부장벽 강화 내지 기능 개선 용도 |
WO2019103381A1 (ko) * | 2017-11-24 | 2019-05-31 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부장벽 강화 내지 기능 개선 용도 |
JP2021506801A (ja) * | 2017-12-14 | 2021-02-22 | メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ | 精製されたエクソソーム生成物、作成方法及び使用方法 |
WO2019139762A1 (en) * | 2018-01-09 | 2019-07-18 | Zen-Bio, Inc. | Exosome compositions and use thereof for joint disorders and diseases |
US20210244769A1 (en) * | 2018-05-04 | 2021-08-12 | Figene, Llc | Pain-reducing effects of fibroblasts and treatment of pain |
RU2710368C2 (ru) * | 2018-05-29 | 2019-12-26 | Станислав Евгеньевич Волчков | Способ получения и концентрирования микроРНК-содержащих экзосом мультипотентных мезенхимально-стромальных клеток для применения в косметических и лекарственных средствах для стимуляции регенеративных процессов и замедления процессов старения |
WO2019231133A1 (ko) * | 2018-05-31 | 2019-12-05 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물 |
KR102649069B1 (ko) * | 2018-05-31 | 2024-03-19 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 안면 홍조 개선용 조성물 |
CN108715834B (zh) * | 2018-06-01 | 2021-09-14 | 天晴干细胞股份有限公司 | 一种富含cd41+、cd81+微囊的血小板裂解液制备方法 |
KR102176845B1 (ko) * | 2018-10-02 | 2020-11-10 | 주식회사 스템온 | 유도된 엑소좀을 포함하는 피부 재생 및 상처 치유용 조성물 |
WO2020180311A1 (en) * | 2019-03-06 | 2020-09-10 | Zen-Bio, Inc. | Plant-based exosome compositions and use thereof for rejuvenating skin |
BR112021021676A2 (pt) * | 2019-04-29 | 2021-12-21 | Direct Biologics Llc | Uso de preparação de exossomo de células-tronco mesenquimais para a preparação de composição para o tratamento da doença periodontal |
JP2021040551A (ja) * | 2019-09-11 | 2021-03-18 | 富士フイルム株式会社 | 培地組成物、キット、間葉系幹細胞組成物の製造方法、間葉系幹細胞組成物、間葉系幹細胞、細胞培養上清および細胞外小胞 |
CN110559254A (zh) * | 2019-10-20 | 2019-12-13 | 张新梅 | 一种外泌体组合物、其制备方法及应用 |
CN110721198A (zh) * | 2019-11-08 | 2020-01-24 | 赵凯 | 一种预防癫痫产生脑损伤的外泌体喷雾的制作工艺 |
WO2022158816A1 (ko) * | 2021-01-20 | 2022-07-28 | 성균관대학교산학협력단 | 줄기세포 유래 엑소좀, 히알루론산, 및 bdde를 포함하는 피부 주름개선용 필러 조성물 및 이의 제조 방법 |
KR102368442B1 (ko) * | 2021-02-19 | 2022-02-28 | 주식회사 엑소코바이오 | 생리활성이 강화된 엑소좀의 생산방법 및 이의 응용 |
CN113041259B (zh) * | 2021-03-23 | 2023-05-12 | 哈尔滨科技实业开发有限公司 | 牙髓干细胞外泌体制剂及制备方法和应用 |
CN113384518A (zh) * | 2021-07-27 | 2021-09-14 | 山西遗传资源细胞库有限公司 | 一种干细胞外泌体应用于面膜的方法 |
WO2023079655A1 (ja) * | 2021-11-04 | 2023-05-11 | 株式会社リバティソリューション | エクソソーム抽出方法 |
CN113940912B (zh) * | 2021-12-09 | 2024-04-16 | 深圳市泓浩生物科技有限公司 | 抗衰老的组合物及其应用 |
CN116099056A (zh) * | 2023-04-07 | 2023-05-12 | 云南云科特色植物提取实验室有限公司 | 一种含仿生纹理结构的人工皮肤及其制备方法 |
CN116790482A (zh) * | 2023-06-12 | 2023-09-22 | 成都诺医德医学检验实验室有限公司 | 一种刺激皮肤类器官分泌外泌体的方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5348945A (en) * | 1990-04-06 | 1994-09-20 | Wake Forest University | Method of treatment with hsp70 |
US5593682A (en) * | 1995-12-29 | 1997-01-14 | Eastman Chemical Company | Skin treating composition |
AT409379B (de) * | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
JP2004331602A (ja) * | 2003-05-09 | 2004-11-25 | Arysta Lifescience Corp | 皮膚外用剤 |
EP1514539A3 (en) * | 2003-05-14 | 2005-05-04 | Signal Investment & Management Co. | Micro-encapsulated topical analgesic for pain relief and sleeve comprising it |
US20060143782A1 (en) * | 2004-10-07 | 2006-07-06 | Sherry Ajluni | Glove with skin lotion |
WO2008086358A1 (en) * | 2007-01-08 | 2008-07-17 | University Of Southern California Usc Stevens | Skin wound healing compositions and methods of use thereof |
JP5718648B2 (ja) * | 2008-02-22 | 2015-05-13 | エイジェンシー・フォー・サイエンス,テクノロジー・アンド・リサーチ(エイ・スター) | 間葉系幹細胞粒子 |
KR101480362B1 (ko) * | 2010-08-23 | 2015-01-28 | 주식회사 강스템바이오텍 | Nod2의 아고니스트를 처리한 줄기세포 또는 그 배양물을 포함하는 면역질환 또는 염증질환의 예방 또는 치료용 약학조성물 |
SG189438A1 (en) * | 2010-10-18 | 2013-05-31 | Agency Science Tech & Res | Use of exosomes to promote or enhance hair growth |
US9119974B2 (en) * | 2011-03-04 | 2015-09-01 | Ahmed H. Al-Qahtani | Skin cream |
EP2683389B1 (en) * | 2011-03-11 | 2017-05-03 | Children's Medical Center Corporation | Methods and compositions relating to mesenchymal stem cell exosomes |
JP3171007U (ja) * | 2011-06-28 | 2011-10-13 | ヘルスアシスト株式会社 | 腕肩美容パックシート |
US9427450B2 (en) * | 2012-01-31 | 2016-08-30 | Xon Cells, Inc. | Therapeutic immune modulation by stem cell secreted exosomes |
EP2687219A1 (en) * | 2012-07-18 | 2014-01-22 | Universität Duisburg-Essen | Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions |
PL2972193T3 (pl) * | 2013-03-13 | 2020-08-24 | University Of Miami | Sposób izolacji i oczyszczania mikropącherzyków z supernatantów hodowli komórkowej i płynów biologicznych |
US20160120805A1 (en) * | 2013-06-05 | 2016-05-05 | The Trustees Of Columbia University In The City Of New York | Exosomes for orofacial diagnostics and therapeutics |
JP2015101541A (ja) * | 2013-11-21 | 2015-06-04 | ポーラ化成工業株式会社 | 皮膚関連酵素活性化剤 |
JP6253361B2 (ja) * | 2013-11-21 | 2017-12-27 | ポーラ化成工業株式会社 | 皮膚外用剤 |
US9464272B2 (en) * | 2013-12-12 | 2016-10-11 | Stemnion, Inc. | Cell-derived composition |
CN104488850B (zh) * | 2014-11-28 | 2016-11-02 | 广州赛莱拉干细胞科技股份有限公司 | 一种制备人羊膜间充质干细胞外泌体冻干粉的方法 |
-
2016
- 2016-07-28 EP EP16833569.3A patent/EP3328397B1/en active Active
- 2016-07-28 EP EP16833568.5A patent/EP3328403A4/en not_active Withdrawn
- 2016-07-28 CA CA2993227A patent/CA2993227C/en active Active
- 2016-07-28 HR HRP20230865TT patent/HRP20230865T1/hr unknown
- 2016-07-28 WO PCT/US2016/044458 patent/WO2017023690A1/en active Application Filing
- 2016-07-28 RS RS20230599A patent/RS64469B1/sr unknown
- 2016-07-28 PL PL16833569.3T patent/PL3328397T3/pl unknown
- 2016-07-28 CA CA2993224A patent/CA2993224A1/en not_active Abandoned
- 2016-07-28 ES ES16833569T patent/ES2952050T3/es active Active
- 2016-07-28 JP JP2018525514A patent/JP6980955B2/ja active Active
- 2016-07-28 JP JP2018525513A patent/JP6719559B2/ja active Active
- 2016-07-28 WO PCT/US2016/044453 patent/WO2017023689A1/en unknown
- 2016-07-28 HU HUE16833569A patent/HUE063486T2/hu unknown
-
2018
- 2018-01-31 US US15/884,545 patent/US20180147420A1/en not_active Abandoned
- 2018-01-31 US US15/884,921 patent/US20180177828A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP3328403A1 (en) | 2018-06-06 |
CA2993227A1 (en) | 2017-02-09 |
EP3328397B1 (en) | 2023-07-12 |
EP3328397C0 (en) | 2023-07-12 |
PL3328397T3 (pl) | 2023-10-16 |
JP2018522593A (ja) | 2018-08-16 |
US20180147420A1 (en) | 2018-05-31 |
CA2993227C (en) | 2020-07-21 |
RS64469B1 (sr) | 2023-09-29 |
US20180177828A1 (en) | 2018-06-28 |
CA2993224A1 (en) | 2017-02-09 |
JP6719559B2 (ja) | 2020-07-08 |
EP3328397A1 (en) | 2018-06-06 |
EP3328403A4 (en) | 2019-04-17 |
HUE063486T2 (hu) | 2024-01-28 |
EP3328397A4 (en) | 2019-04-03 |
WO2017023690A1 (en) | 2017-02-09 |
WO2017023689A1 (en) | 2017-02-09 |
ES2952050T3 (es) | 2023-10-26 |
JP2018522071A (ja) | 2018-08-09 |
JP6980955B2 (ja) | 2021-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20230865T1 (hr) | Kompozicije egzosoma i postupci za njihovu pripremu i primjenu za reguliranje i kondicioniranje kože i kose | |
JP2018522071A5 (hr) | ||
IN2014DN06546A (hr) | ||
MY172073A (en) | Bioactive botanical cosmetic compositions and processes for their production | |
WO2014053038A3 (en) | Plant lipid composition for modulating functions of keratinous materials, method for modulating said functions and use of said plant lipids | |
Lee et al. | A fermented barley and soybean formula enhances skin hydration | |
CN106470665B (zh) | 具有减少刺激的化妆品组合物 | |
US20200113800A1 (en) | Cosmetic composition | |
MX2014014517A (es) | Composiciones topicas bajo la forma de un gel que contiene un retinoide particular solubilizado. | |
JP2015508790A5 (hr) | ||
BR112012033090A2 (pt) | uso de ácido caftárico e derivados em suplemento alimentar para regulagem de pigmentação da pele | |
JP6993076B2 (ja) | 皮下組織構造の改善成分のスクリーニング方法 | |
EA028472B9 (ru) | Композиция по уходу за кожей | |
JP2014159389A (ja) | フィラグリン産生促進剤および皮膚外用剤 | |
CN104306277A (zh) | 一种黄瓜爽肤水及其制备方法 | |
JP2022136172A (ja) | 皮膚用組成物 | |
WO2013066481A3 (en) | Cosmetic use of n-heteroarylbisamide analogs and related compounds | |
NZ705592A (en) | Quick-penetrating soft skin-care cream | |
JP2016121135A (ja) | 毛髪用剤 | |
CN103565674A (zh) | 霍霍巴油雪花膏 | |
JP2019081718A (ja) | ヒアルロン酸合成酵素発現促進剤 | |
BR112017022026A2 (pt) | composições para formulação cosmética de hidratação prolongada compreendendo manteiga de ucuuba com elevada concentração de ácido mirístico, bem como uso da dita formulação para preparação de um produto cosmético com alto poder hidrante e kit | |
CN102885709A (zh) | 祛斑去皱美容面霜及其制备方法 | |
CN107427424B (zh) | 用于增强皮肤屏障的口服施用的美容组合物 | |
CN103494722A (zh) | 罗氏槲果籽油桃保湿霜 |